Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes

NACompletedINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions
Abdominal PainDeglutition DisordersFecal IncontinenceNauseaDiarrheaConstipationGastroesophageal Reflux
Interventions
OTHER

AEGIS (Automated Evaluation of Gastrointestinal Symptoms)

"AEGIS (Automated Evaluation of Gastrointestinal Symptoms) guides patients through questionnaires to measure symptom attributes including the timing, severity, frequency, location, quality, and character of their gastrointestinal (GI) symptoms, along with relevant comorbidities, family history, and alarm features. This information is transformed into a history of present illness (HPI) written in language familiar to clinicians. AEGIS also supports both the clinician and patient with an individualized education prescription which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments. The prescription is created by the portal based on each patient's unique AEGIS fingerprint."

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT02530216 - Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes | Biotech Hunter | Biotech Hunter